Leadership Overview
Gufic Group has 5 executives leading key functions including operations, finance, human resources, sales, and marketing.
Driven by a commitment to innovation, Gufic Group is dedicated to advancing pharmaceutical and herbal products, impacting healthcare through high-quality manufacturing and extensive distribution networks.
Driven by a commitment to innovation, Gufic Group is dedicated to advancing pharmaceutical and herbal products, impacting healthcare through high-quality manufacturing and extensive distribution networks.
Leadership Roles at Gufic Group
Devkinandan Roonghta - Chief Financial Officer
Devkinandan Roonghta, the Chief Financial Officer at Gufic Group, manages all financial strategies and fiscal operations. Roonghta oversees budgeting, financial planning, and resource allocation to support Gufic's growth objectives in the pharmaceutical and herbal product sectors. This critical position involves ensuring financial stability and profitability while facilitating investments in research and development for new product launches. The Chief Financial Officer plays a key part in managing the financial aspects of expanding the company's international footprint and maintaining its status as a leading manufacturer of lyophilized injections. Devkinandan Roonghta's financial oversight ensures compliance with regulatory requirements and optimizes the financial performance across all business units, including API production and critical care product lines. Roonghta's expertise guides strategic financial decisions, reinforcing Gufic's market leadership.
Nagesh Yarrabathina - Chief Operating Officer
Nagesh Yarrabathina, the Chief Operating Officer at Gufic Group, directs all operational facets of the pharmaceutical manufacturing business. Overseeing the production of lyophilized injections, antibiotics, antifungals, and antiviral treatments, Yarrabathina ensures adherence to stringent quality standards. This leadership role involves optimizing manufacturing processes to maintain Gufic's position as one of India's largest producers of lyophilized injectables. By managing the supply chain, the Chief Operating Officer facilitates the distribution of critical pharmaceutical products to major hospital chains and medical facilities across India. Nagesh Yarrabathina drives operational efficiency, supporting the company's continuous launch of advanced new products and its expansion into international markets. The Chief Operating Officer's focus remains on scalable production and reliable delivery, underpinning the group's market presence.
Rajesh Kaul - Senior President
Rajesh Kaul, the Senior President at Gufic Group, drives strategic initiatives across key business segments. Kaul's leadership focuses on enhancing Gufic's market position in pharmaceuticals and herbal products, particularly in critical care areas. This role involves overseeing the expansion of the company's product portfolio, including antibiotics, antifungals, and antiviral treatments, and ensuring their effective delivery to major hospital chains. The Senior President plays a vital part in guiding the company's research and development efforts, fostering the launch of advanced new products. Rajesh Kaul's strategic direction supports Gufic's growing international presence and its commitment to manufacturing excellence, especially in lyophilized injections. Kaul's oversight ensures alignment with corporate objectives, driving growth and reinforcing Gufic's reputation for quality and innovation.
Shekhar Aley - President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare
Shekhar Aley, the President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare at Gufic Group, directs all sales and marketing operations for critical care business units within India and Nepal, focusing on neurocare. Aley is responsible for developing and executing go-to-market strategies for Gufic's diverse pharmaceutical and herbal product range, including antibiotics, antifungals, and antiviral treatments. This leadership position involves expanding market share and driving revenue growth through targeted campaigns and robust distribution channels to major hospital chains and medical facilities. The President, Sales & Marketing-Critical Care Sbus Indianepalinneurocare ensures effective promotion of Gufic's high-quality products, including its extensive line of lyophilized injections. Shekhar Aley's strategic vision supports the company's commitment to research and development, facilitating the launch of advanced new products and strengthening Gufic's brand presence in key therapeutic areas.
Sunil Desai - Chief Human Resources Officer
Sunil Desai, the Chief Human Resources Officer at Gufic Group, leads all human capital management initiatives. Desai is responsible for developing and implementing HR strategies that align with Gufic's mission of innovation and quality in pharmaceutical and herbal products. This role involves talent acquisition, employee development, and fostering a positive organizational culture across manufacturing, sales, and research departments. The Chief Human Resources Officer ensures that Gufic Group attracts and retains top talent necessary for producing high-quality products, including lyophilized injections and APIs. Sunil Desai oversees employee relations and performance management systems, supporting the company's expansion into new markets and the continuous launch of advanced products. Desai's strategic approach to HR strengthens the workforce, enabling Gufic to meet its operational and developmental goals effectively.
Explore Leadership Teams in Manufacturing
PCI Pharma Services is an integrated full service provider to companies in the global healthcare industry. They offer services including analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage, and distribution. They are headquartered in Philadelphia, Pennsylvania with locations in the United States and Europe.
Company Leadership AF
KS
Chemipharm is the only company selling directly to 100% of the reachable pharmacies and hospitals in Egypt. Chemipharm's distribution network includes: 12 branches allover Egypt. 100 fixed routes every day. Total 150 visiting all the pharmacies all over the country. Latest News : PROFILE Company Profile: Chemipharm was founded in 1972 by Dr. Gamal Kamel as the first private sector importer of pharmaceutical products in Egypt. Over the last 35 years, Chemipharm has developed and maintained an invaluable reputation as Egypt's most respectable and high standards pharmaceutical distributor. In 2003, based on the company's continuous growth, Chemipharm has established its own manufacturing facility in the 6th of October Industrial Zone. Plant was designed by Pharma Consult. The modern GMP plant produces pharmaceutical products of all major forms (tablets, capsules, syrups and ointments). Presently Chemipharm is constructing a new sterile area to produce ampoules, eye drops and antibiotics. The company's strategy is based on continuous improvement and growth.
Company Leadership KK
DO
NM
Founded in 1997 and headquartered in West Columbia, South Carolina, Nephron Pharmaceuticals manufactures generic respiratory medications.
Company Leadership JM
PK
AG
Founded in 1994 and headquartered in Shanghai, China, Fosun Pharma is a company that focuses on the research and development and manufacturing of pharmaceuticals.
Company Leadership AD
AH
YS
LC
Frequently Asked Questions Regarding Gufic Group Top Executives and Leadership Team
